Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128(b)(4) — License Revocation/Suspension · Date: 12/18/2025 · State: NJ
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
3,540
Total Claims
$335K
Drug Cost
228
Beneficiaries
$1,471
Cost/Patient
Risk Score Breakdown 45/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+450%
Opioid rate vs peers
14.2% vs 2.6% avg
+38%
Cost per patient vs peers
$1,471 vs $1,068 avg
-1%
Brand preference vs peers
8.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider appears on the federal OIG exclusion list, meaning they have been formally barred from participating in federal healthcare programs due to fraud, patient abuse, licensing issues, or other misconduct. The fact that they still appear in active prescribing data is a significant concern.
Opioid rate is 450% above Family Practice peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
14.2%
Opioid Rate
502
Opioid Claims
$46K
Opioid Cost
5.4%
Long-Acting Rate
Brand vs Generic
Brand: 312 claims · $239K
Generic: 3,204 claims · $95K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Brexpiprazole | 18 | $52K |
| Apixaban | 25 | $28K |
| Oxycodone Hcl | 24 | $21K |
| Empagliflozin | 22 | $19K |
| Dapagliflozin Propanediol | 16 | $14K |
| Vortioxetine Hydrobromide | 17 | $13K |
| Fluticasone/Umeclidin/Vilanter | 14 | $11K |
| Hydrocodone/Ibuprofen | 25 | $7,864 |
| Oxycodone Hcl | 201 | $7,811 |
| Alprazolam | 271 | $4,793 |
| Hydromorphone Hcl | 76 | $3,546 |
| Lidocaine | 13 | $3,517 |
| Hydrocodone/Acetaminophen | 81 | $3,430 |
| Butorphanol Tartrate | 13 | $2,783 |
| Dextroamphetamine/Amphetamine | 42 | $2,449 |
Prescribing Profile
Patient Profile
72
Avg Age
56%
Female
1.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data